|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sealing Pond bottoms with muddy water显示文摘 | Herman B Jamie L Robert C R | 2001 | Ecological Engineering2001，18，2： | 1 |
| 2 | 早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。 | Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 | 2016 | 中国全科医学2016，19，18： | 1 |
| 3 | Relationship between self - efficacy and physical activity among patients with type 2 diabetes显示文摘 | Gareth R Bridgette C Jamie L | 2009 | Behavior Med )2009，32，： | 1 |
| 4 | Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition显示文摘 | Peters Anne L Buschur Elizabeth O Buse John B Cohan Pejman Diner Jamie C Hirsch Irl B | 2015 | Diabetes Care2015，，9： | 1 |
| 5 | Targeted disruption of the α1,3-galactosytransferase gene in cloned pigs显示文摘 | Todd D V Jeremy B Shu-Hung Chen Carol J P Suyapa B Jeff A M Peter M J Kenneth J M Ashley E Lamborn Jamie L Cowell-Lucero Kevin D W Alan C Irina A P David L A | 2002 | Nat Biotechnology2002，20，3： | 1 |
| 6 | Reflection of modified Korteweg-de Vries solitons in a negative ion plasma显示文摘 | S Yi Jamie L C H S Kim | 1996 | Phys Plasmas1996，3，： | 1 |
| 7 | Modifications to physicochemical and nutritional properties of hard -to -cook beans (Phaseolus vulgaris L) by extrusion cooking显示文摘 | MARTIN-CABREJAS M A JAMIE L KARANJA C et al | 1999 | Journal of Agricultural and Food Chemistry1999，47，3： | 1 |
| 8 | The Can- cer Pain Inventory: preliminary development and valida- tion显示文摘 | Teresa L Raymond C Jamie Manwaring | 2010 | Psycho-Oncology2010，19，7： | 1 |
| 9 | Isothermal Strand-Displacement Amplification Applications for High-Throughput Genomics显示文摘 | John C Detter Jamie M Jett Susan M Lucas Eileen Dalin Andre R Arellano Mei Wang John R Nelson Jarrod Chapman Yunian Lou Dan Rokhsar Trevor L Hawkins Paul M Richardson | 2002 | Genomics2002，，6： | 1 |
| 10 | Novel immunohistoehemical localization of 28 000 molecular-weight( Mr ) calcium binding protein ( calbindin-D28k ) in enterochromaffin cells of the human appendix and neuroendoerine tumors(carcinoids and small-cell carcinomas)of the midgut and foregut 显示文摘 | Katsetos C D Jami M M Krishna L et al | 1994 | Arch Pathol Lab Med1994，118，6： | 1 |
| 11 | Conventional and PCR detection of Aphelenchoides fragariae in diverse ornamental host plant species显示文摘 | Jamie L McCuiston Laura C | 2007 | Journal of Nematology2007，39，4： | 1 |
| 12 | Risk perception and knowledge of COVID-19 in patients with celiac disease显示文摘BACKGROUND We recently demonstrated that the odds of contracting coronavirus disease 2019(COVID-19)in patients with celiac disease(CeD)is similar to that of the general population.However,how patients with CeD perceive their COVID-19 risk may differ from their actual risk.AIM To investigate risk perceptions of contracting COVID-19 in patients with CeD and determine the factors that may influence their perception.METHODS We distributed a survey throughout 10 countries between March and June 2020 and collected data on demographics,diet,COVID-19 testing,and risk perceptions of COVID-19 in patients with CeD.Participants were recruited through various celiac associations,clinic visits,and social media.Risk perception was assessed by asking individuals whether they believe patients with CeD are at an increased risk of contracting COVID-19 when compared to the general population.Logistic regression was used to determine the influencing factors associated with COVID-19 risk perception,such as age,sex,adherence to a gluten-free diet(GFD),and comorbidities such as cardiac conditions,respiratory conditions,and diabetes.Data was presented as adjusted odds ratios(aORs)RESULTS A total of 10737 participants with CeD completed the survey.From them,6019(56.1%)patients with CeD perceived they were at a higher risk or were unsure if they were at a higher risk of contracting COVID-19 compared to the non-CeD population.A greater proportion of patients with CeD perceived an increased risk of contracting COVID-19 when compared to infections in general due to their CeD(56.1%vs 26.7%,P<0.0001).Consequently,34.8%reported taking extra COVID-19 precautions as a result of their CeD.Members of celiac associations were less likely to perceive an increased risk of COVID-19 when compared to non-members(49.5%vs 57.4%,P<0.0001).Older age(aOR:0.99;95%CI:0.99 to 0.99,P<0.001),male sex(aOR:0.84;95%CI:0.76 to 0.93,P=0.001),and strict adherence to a GFD(aOR:0.89;95%CI:0.82 to 0.96,P=0.007)were associated with a lower perception of COVID-19 risk and the presence of comorbidities was associated with a higher perception of COVID-19 risk(aOR:1.38;95%CI:1.22 to 1.54,P<0.001).CONCLUSION Overall,high levels of risk perceptions,such as those found in patients with CeD,may increase an individual’s pandemic-related stress and contribute to negative mental health consequences.Therefore,it is encouraged that public health officials maintain consistent communication with the public and healthcare providers with the celiac community.Future studies specifically evaluating mental health in CeD could help determine the consequences of increased risk perceptions in this population. | Jamie Zhen Juan Pablo Stefanolo María de la Paz Temprano Caroline L Seiler Alberto Caminero Enrique de-Madaria Miguel Montoro Huguet Vivas Santiago Sonia Isabel Niveloni Edgardo Gustavo Smecuol Luis Uzcanga Dominguez Elena Trucco Virginia Lopez Carolina Olano Pasquale Mansueto Antonio Carroccio Peter H Green Donald Duerksen Andrew S Day Jason A Tye-Din Julio César Bai Carolina Ciacci Elena F Verdú Benjamin Lebwohl M Ines Pinto-Sanchez | 2021 | World Journal of Gastroenterology2021，27，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员